Developments in the treatment of gastrointestinal parasites of small animals.
The use of anthelmintics introduced over the past 25 years is discussed. The spectrum of action, efficacy, and toxicity of benzimidazoles, ivermectin, milbemycin, praziquantel, and epsiprantel are considered.
Zajac
A M
AM
Department of Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Blacksburg.
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000923:Anticestodal Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002371:Cat Diseases / Q000188:drug therapy* / Q000469:parasitology; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy* / Q000469:parasitology; D004285:Dogs; D005273:Fenbendazole / Q000627:therapeutic use; D005544:Forecasting; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D007559:Ivermectin / Q000627:therapeutic use; D007783:Lactones / Q000627:therapeutic use*; D018942:Macrolides; D008463:Mebendazole / Q000627:therapeutic use; D010272:Parasitic Diseases / Q000188:drug therapy; D010273:Parasitic Diseases, Animal; D011223:Praziquantel / Q000031:analogs & derivatives / Q000627:therapeutic use
D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D000923:Anticestodal Agents; D001562:Benzimidazoles; D007783:Lactones; D018942:Macrolides; C060885:epsiprantel; D005273:Fenbendazole; D011223:Praziquantel; D007559:Ivermectin; D008463:Mebendazole; C027837:moxidectin